Free Trial

Agilon Health (NYSE:AGL) Shares Down 5.2% on Analyst Downgrade

Agilon Health logo with Medical background

Agilon Health, Inc. (NYSE:AGL - Get Free Report)'s stock price was down 5.2% during trading on Wednesday after Evercore ISI lowered their price target on the stock from $5.00 to $3.00. Evercore ISI currently has an in-line rating on the stock. Agilon Health traded as low as $2.26 and last traded at $2.27. Approximately 412,174 shares traded hands during trading, a decline of 92% from the average daily volume of 5,292,059 shares. The stock had previously closed at $2.39.

AGL has been the topic of several other reports. Robert W. Baird cut their target price on Agilon Health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 15th. Needham & Company LLC reaffirmed a "hold" rating on shares of Agilon Health in a research report on Friday, March 21st. The Goldman Sachs Group lifted their target price on Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. Citigroup raised Agilon Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $3.25 to $5.00 in a research report on Friday, April 25th. Finally, Sanford C. Bernstein upgraded Agilon Health from a "market perform" rating to an "outperform" rating and lifted their price target for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $4.71.

Get Our Latest Stock Report on Agilon Health

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in AGL. Nisa Investment Advisors LLC boosted its position in Agilon Health by 244.9% during the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after acquiring an additional 6,783 shares during the period. Gabelli Funds LLC acquired a new position in Agilon Health during the 1st quarter worth $48,000. Signaturefd LLC boosted its position in Agilon Health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after acquiring an additional 8,467 shares during the period. Ridgecrest Wealth Partners LLC acquired a new position in Agilon Health during the 1st quarter worth $65,000. Finally, Pallas Capital Advisors LLC acquired a new position in Agilon Health during the 1st quarter worth $66,000.

Agilon Health Trading Up 1.1%

The stock has a 50-day simple moving average of $2.51 and a 200-day simple moving average of $3.22. The company has a market cap of $958.29 million, a price-to-earnings ratio of -3.92 and a beta of 0.16.

Agilon Health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.04. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The company's revenue was down 4.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.02) earnings per share. As a group, research analysts expect that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

About Agilon Health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Should You Invest $1,000 in Agilon Health Right Now?

Before you consider Agilon Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.

While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines